These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22014164)

  • 1. Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma.
    Chu PY; Hsu NC; Liao AT; Shih NY; Hou MF; Liu CH
    BMC Vet Res; 2011 Oct; 7():62. PubMed ID: 22014164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Krüppel-like factor 4 transcription factor in canine mammary carcinoma.
    Chu PY; Hsu NC; Liao AT; Yeh KT; Hou MF; Liu CH
    BMC Vet Res; 2011 Oct; 7():58. PubMed ID: 21978458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
    Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
    Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic value of c-met in canine mammary tumours.
    Chen YC; Chen YY; Liao JW; Chang SC
    Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report on the expression of leptin and leptin receptor (ObR) in normal, hyperplastic and neoplastic canine mammary tissues.
    Ressel L; Finotello R; Innocenti VM; Vannozzi I; Poli A
    Res Vet Sci; 2012 Aug; 93(1):343-9. PubMed ID: 21875727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
    Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
    Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
    Gama A; Gärtner F; Alves A; Schmitt F
    Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of ATM Gene and Protein Expression in Canine Mammary Tumors.
    Raposo-Ferreira TM; Bueno RC; Terra EM; Avante ML; Tinucci-Costa M; Carvalho M; Cassali GD; Linde SD; Rogatto SR; Laufer-Amorim R
    Vet Pathol; 2016 Nov; 53(6):1154-1159. PubMed ID: 27106737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
    Pastor N; Ezquerra LJ; Santella M; Caballé NC; Tarazona R; Durán ME
    Vet Comp Oncol; 2020 Dec; 18(4):753-762. PubMed ID: 32336005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
    Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
    Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
    Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and Roles of S100A4 in Anaplastic Cells of Canine Mammary Carcinomas.
    Yoshimura H; Otsuka A; Michishita M; Yamamoto M; Ashizawa M; Zushi M; Moriya M; Azakami D; Ochiai K; Matsuda Y; Ishiwata T; Kamiya S; Takahashi K
    Vet Pathol; 2019 May; 56(3):389-398. PubMed ID: 30686112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemoglobin in normal and neoplastic canine mammary glands.
    Chang SC; Chen HF; Chou MH; Wang HC; Su HY; Wong ML
    Vet Comp Oncol; 2010 Dec; 8(4):302-9. PubMed ID: 21062412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.
    Michel E; Feldmann SK; Kowalewski MP; Bley CR; Boos A; Guscetti F; Reichler IM
    BMC Vet Res; 2012 May; 8():72. PubMed ID: 22647582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.